Award notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
Record references
- Release reference
045153-2025- Published tags
- award, contract
Loading records…
Public procurement
See the published facts, notice history, awards and supplier links in one place. Open the original Find a Tender notice for the full record.
ocds-h6vhtk-055064Published facts
062482-2025NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Offer reference number: CM/PHS/25/5728 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments: 7NAT (National) 01/12/2025 to 31/05/2027 (18 months) CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg: NOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) SOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) MAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months) LNW: (London) 01/12/2025 to 31/05/2027 (18 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Provision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye
Observed notice trail
Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.
Award notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
045153-2025Award notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
062482-2025Awards and suppliers
Buyer: NHS EnglandSupplier: ALIMERA SCIENCES LIMITED
2Buyer: NHS EnglandSupplier: Abbvie Ltd
End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.
2Buyer: NHS EnglandSupplier: BIOSIMILAR COLLABORATIONS IRELAND LIMITED
2Buyer: NHS EnglandSupplier: Bayer
2Buyer: NHS EnglandSupplier: Biogen Ltd.
2Buyer: NHS EnglandSupplier: Celltrion Healthcare United Kingdom Limited
2Buyer: NHS EnglandSupplier: MDBIOLOGICS LTD
2Buyer: NHS EnglandSupplier: Novartis Pharmaceuticals UK Ltd
2Buyer: NHS EnglandSupplier: ORION PHARMA (UK) LIMITED
2Buyer: NHS EnglandSupplier: Outlook Therapeutics, Inc.
2Buyer: NHS EnglandSupplier: Roche Products Ltd
2Buyer: NHS EnglandSupplier: SANDOZ LIMITED
2Buyer: NHS EnglandSupplier: THORNTON & ROSS LIMITED
2Buyer: NHS EnglandSupplier: Teva UK Limited
2Buyer: NHS EnglandSupplier: BIOSIMILAR COLLABORATIONS IRELAND LIMITED
3Buyer: NHS EnglandSupplier: Bayer Plc
3Buyer: NHS EnglandSupplier: Celltrion Healthcare
3Buyer: NHS EnglandSupplier: MDBIOLOGICS LTD
3Buyer: NHS EnglandSupplier: Sandoz Ltd
3